Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Receivables - Other (2020 - 2024)

Historic Receivables - Other for Cellebrite DI (CLBT) over the last 5 years, with Q4 2024 value amounting to $81.3 million.

  • Cellebrite DI's Receivables - Other fell 878.4% to $81.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $81.3 million, marking a year-over-year decrease of 878.4%. This contributed to the annual value of $81.3 million for FY2024, which is 878.4% down from last year.
  • As of Q4 2024, Cellebrite DI's Receivables - Other stood at $81.3 million, which was down 878.4% from $89.2 million recorded in Q4 2023.
  • In the past 5 years, Cellebrite DI's Receivables - Other ranged from a high of $89.2 million in Q4 2023 and a low of $33.9 million during Q4 2020
  • Over the past 5 years, Cellebrite DI's median Receivables - Other value was $81.3 million (recorded in 2024), while the average stood at $71.6 million.
  • Its Receivables - Other has fluctuated over the past 5 years, first soared by 11312.86% in 2021, then plummeted by 878.4% in 2024.
  • Cellebrite DI's Receivables - Other (Quarter) stood at $33.9 million in 2020, then surged by 113.13% to $72.3 million in 2021, then rose by 12.83% to $81.5 million in 2022, then rose by 9.38% to $89.2 million in 2023, then fell by 8.78% to $81.3 million in 2024.
  • Its Receivables - Other was $81.3 million in Q4 2024, compared to $89.2 million in Q4 2023 and $81.5 million in Q4 2022.